Home Stocks Ideaya picks cancer drug candidate, targets human trial application in 2027 (IDYA:NASDAQ)

Ideaya picks cancer drug candidate, targets human trial application in 2027 (IDYA:NASDAQ)

by Deidre Salcido
0 comments
Image 1453597080.jpg

Phynart Studio

Ideaya Biosciences (IDYA) on Sunday said it selected IDE101 as a drug candidate for further development to treat cancers lacking CDKN2A, a gene that normally helps prevent uncontrolled cell growth. The company aims to seek U.S. regulatory permission to begin human testing

You may also like

Leave a Comment

About Us

Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.

© 2025 AI Investor Picks – All Rights Reserved

AI Investor Picks